WilmerHale Event – Drug Development: Deals and Disclosures

  • 3.16.2006 | -

Belinda Juran

WilmerHale Partner Belinda Juran presented on the panel “20 Questions for Your Lawyer about Drug Development Alliances” during WilmerHale's conference on Drug Development: Deals and Disclosures on March 16, 2006.



Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Rss Feed
2.25.2025
Framework unveils new repairable and upgradeable laptops and desktop 
2.25.2025
OpenAI drops Deep Research access to Plus users, heating up AI agent wars with DeepSeek and Claude 
2.25.2025
Wonder Woman video game, announced in 2021, reportedly canceled 
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

2.20.2025
Corporate Transparency Act: Judge Clears Way for CTA; Reporting Requirements Back in Effect
2.12.2025
Corporate Transparency Act: It’s Still Paused (For Now)
12.27.2024
Corporate Transparency Act: Preliminary Injunctive Relief Reinstated by Fifth Circuit (For Now)